Udayavni Special

AstraZeneca, J&J resume Covid-19 vaccine trial in US


Team Udayavani, Oct 24, 2020, 11:56 AM IST

Washington: AstraZeneca and Johnson & Johnson have resumed COVID-19 vaccine trial in the United States, after briefly pausing the trials over “unexplained illness” in few volunteers.

Both the companies on Friday said that the “unexplained illness” in few volunteers appeared not to be related to the vaccine shot.

The final stage of testing of the COVID-19 vaccine candidate was paused in the US, as officials examine whether an illness in its trial poses a safety risk. That trial was stopped when a woman developed severe neurological symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, AstraZeneca said. However, the vaccine’s testing has resumed in other countries.

After a six-week pause, Federal health regulators gave AstraZeneca the go-ahead to resume the trials in US, concluding there was no evidence that the experimental vaccine had directly caused the neurological side effects reported in two participants.

Johnson & Johnson said that its trial, which had been on pause for 11 days, would restart after learning that a “serious medical event” in one study volunteer had “no clear cause.”

A Food and Drug Administration spokesperson declined to comment on the trial restarts.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Pakistan fails to nab 19 most wanted LeT terrorists even 12 years after 26/11 attack

Speculation rife in Karnataka as CM convenes meeting of cabinet, MPs

Farmers’ protest: Vigil stepped up in Delhi’s bordering areas, vehicles being checked

Khattar hits out at Amarinder, tells him to stop ‘inciting’ innocent farmers

PM Modi to visit Serum Institute of India in Pune on Saturday

Militant attack in J&K, two security personnel killed

WhatsApp OTP scam: What is it and how to stay safe?



Related Articles More

K’taka COVID-19 update: 1630 new cases, 1333 discharges, 19 deaths on Nov 24

PM has indicated COVID vaccine likely to be ready soon: Yediyurappa

K’taka COVID-19 update: 1870 new cases, 1949 discharges, 17 deaths on Nov 23

Thanksgiving could be make-or-break in US virus response

COVID-19 vaccine: India Aatmanirbhar for syringes, says industry

MUST WATCH

Madhavashankara name for Mangalore airport: Shri Sugunendra Tirtha Swamiji

Centuries-old Tuluva ritual of ‘Bhoomipuje Gaddekori’ still performed at Palthadi Village in Puttur

A bike rider dies in a lorry crash : The scene of the accident was captured on CCTV

Moodbidri: Four people drowned in Shambhavi river

1348 new vented dams in K’taka’s coastal districts: J.C. Madhu Swamy

Latest Additions

Chinese Premier Li to Attend SCO Heads of Govt Meeting Hosted by India on November 30

Phone Call Row: RJD Chief Lalu Prasad Shifted from Hospital Director’s Bungalow to Paying Ward

India, Nepal Agree to Advance Ties as Foreign Secretary Meets Nepalese Top Leadership

Former Assam CM Tarun Gogoi Cremated With Full State Honours in Guwahati

UP govt extends ban on strikes in state departments for 6 months

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.